Skip to main content
BIIB logo
BIIB
(NASDAQ)
Biogen Inc.
$177.34-- (--)
Loading... - Market loading

Biogen Inc. (BIIB) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Biogen Inc. stock.

Analyst Consensus Rating

Investment consensus from 34 professional research analysts

Consensus Rating

Hold
Based on 34 unique analysts
(62 total ratings in last 90 days)
Very High Confidence13.0:1 Buy/Sell

Average Price Target

$209.03
17.87% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest BIIB Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Andrew S. Fein
HC Wainwright
Strong BuyMaintains
$228.00 $237.00
PerPlexity Drug Manufacturers - General
TipRanks - PerPlexity
BuyReiterates
$226.00 $205.00
Sumant Kulkarni
Canaccord Genuity
Strong BuyMaintains
$230.00 $245.00
Jay Olson
Oppenheimer
BuyMaintains
$250.00 $275.00
Thomas Shrader
BTIG
HoldMaintains
-
Geoff Meacham
Citi
HoldMaintains
$215.00
Myles Minter
William Blair
BuyReiterates
-
Phil Nadeau
TD Cowen
BuyReiterates
$215.00
Jason Zemansky
BofA Securities
HoldMaintains
$207.00
Evan Seigerman
BMO Capital
HoldMaintains
$196.00
Ami Fadia
Needham
HoldMaintains
-
Michael Yee
UBS
HoldMaintains
$185.00
Terence Flynn
Morgan Stanley
HoldMaintains
$190.00
Salveen Richter
Goldman Sachs
BuyInitiates Coverage
$225.00 $231.00
Rajesh Kumar
HSBC
SellMaintains
$143.00 $150.00
Andrew Tsai
Jefferies
BuyMaintains
$210.00
Brian Abrahams
RBC Capital
BuyMaintains
$233.00
Ilya Zubkov
Freedom Broker
HoldMaintains
$160.00 $185.00
Emily Field
Barclays
HoldInitiates
$185.00
David Amsellem
Piper Sandler
HoldReiterates
$177.00
Salim Syed
Mizuho
BuyMaintains
$207.00 $236.00
Paul Matteis
Stifel Nicolaus
BuyMaintains
$202.00 $214.00
Laura Chico
Wedbush
HoldMaintains
$178.00 $187.00
Sumant Kulkarni
Canaccord Genuity
Strong BuyMaintains
$220.00 $230.00
Laura Chico
Wedbush
HoldMaintains
$178.00 $187.00
Yatin Suneja
Guggenheim
Strong BuyMaintains
$185.00 $246.00
Andrew S. Fein
HC Wainwright
Strong BuyMaintains
$194.00 $228.00
David Amsellem
Piper Sandler
HoldMaintains
$157.00 $177.00
Srikripa Devarakonda
Truist
HoldMaintains
$190.00 $193.00
Phil Nadeau
TD Cowen
Strong BuyMaintains
$175.00 $215.00
Salveen Richter
Goldman Sachs
BuyMaintains
$225.00 $231.00
Evan Seigerman
BMO Capital
HoldMaintains
$165.00 $196.00
Geoff Meacham
Citi
HoldMaintains
$185.00 $215.00
Mohit Bansal
Wells Fargo
HoldMaintains
$190.00 $200.00
Brian Abrahams
RBC Capital
BuyMaintains
$217.00 $233.00
Yatin Suneja
Guggenheim
BuyReiterates
$185.00 $246.00
Google Drug Manufacturers - General
TipRanks - Google
HoldUpgrades
$204.00 $219.00
PerPlexity Drug Manufacturers - General
TipRanks - PerPlexity
BuyReiterates
$195.00 $226.00
Anthropic Drug Manufacturers - General
TipRanks - Anthropic
HoldUpgrades
$198.00 $206.00
DeepSeek Drug Manufacturers - General
TipRanks - DeepSeek
HoldUpgrades
$195.00 $215.00
xAi Drug Manufacturers - General
TipRanks - xAI
BuyReiterates
$199.00 $223.00
OpenAI Drug Manufacturers - General
TipRanks - OpenAI
HoldUpgrades
$168.00 $215.00
Sumant Kulkarni
Canaccord Genuity
BuyReiterates
$220.00 $230.00
Myles Minter
William Blair
BuyMaintains
-
William Pickering
Bernstein
HoldMaintains
$197.00 $201.00
Jason Zemansky
BofA Securities
HoldReiterates
$187.00 $207.00
Michael Yee
UBS
HoldMaintains
$185.00
Ami Fadia
Needham
HoldMaintains
-
Brian Abrahams
RBC Capital
BuyMaintains
$217.00 $233.00
Andrew Tsai
Jefferies
BuyMaintains
$210.00
Jay Olson
Oppenheimer
BuyMaintains
$205.00 $225.00
Chris Schott
JP Morgan
HoldMaintains
$185.00 $175.00
Geoff Meacham
Citi
HoldMaintains
$180.00 $185.00
Thomas Shrader
BTIG
HoldMaintains
-
Evan Seigerman
BMO Capital
HoldMaintains
$165.00
Jasper Hellweg
Argus Research
HoldMaintains
-
Salveen Richter
Goldman Sachs
BuyMaintains
$197.00 $225.00
Srikripa Devarakonda
Truist
HoldMaintains
$142.00 $190.00
Salim Syed
Mizuho
BuyMaintains
$177.00 $207.00
Michael Yee
UBS
HoldInitiates
$130.00 $185.00
Geoff Meacham
Citi
HoldMaintains
$153.00 $180.00
Geoff Meacham
Citi
HoldMaintains
$153.00 $180.00

Frequently Asked Questions

What is the analyst consensus rating for BIIB?

The analyst consensus rating for BIIB is "Hold" based on 34 analyst recommendations.

What is the average price target for BIIB?

The average 12-month price target for BIIB is $209.03, representing an upside of 17.9% from the current price of $177.34.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.